Myelodysplastic syndromes (MDS) are a group of disorders in which a person’s bone marrow does not produce enough functioning blood cells. MDS is a type of cancer that damages some of the blood-forming ...
Myelodysplastic syndromes (MDS; also known as myelodysplastic neoplasms) encompass a spectrum of related, phenotypically and genotypically diverse myeloid cancers. MDS are characterized by ineffective ...
Myelodysplastic syndromes (MDS) and autoimmune conditions can overlap, and each may raise the risk of the other. Up to 30% of people with MDS also have an autoimmune disorder. Autoimmune conditions ...
Dr. Shaal Patel, a board certified physician in hematology, oncology, and internal medicine, spoke with Healthline about how myelodysplastic syndromes (MDS) can benefit from supportive therapy, ...
Show More From the Department of Hematology and Medical Oncology, Moffitt Cancer Center and the University of South Florida, Tampa, FL; Department of Pathology and Immunology, Washington University ...
MDS arise from a small population of disease-initiating HSCs that persist and expand through conventional therapies and are major contributors to disease progression 1,2,3,4. In the last few years, ...
Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting Myelodysplastic syndromes (MDS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results